Management of retinopathy of prematurity in a tertiary referral neonatal intensive care unit: Treatment rates and the impact of outsourcing laser therapy

Retinal Diseases

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

Am J Ophthalmol

Chang E, Josan A, Purohit R, Aslam SA, Hartley C, Patel CK, Xue K

doi: 10.1016/j.ajo.2025.02.040

Retinal Diseases

A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity

Ophthalmol Retina

Baiad AA, Sun C, Yin GS, Popovic MM, Muni RH, Mireskandari K, Kertes PJ

doi: 10.1016/j.oret.2025.01.012

Retinal Diseases

Prediction of retinopathy of prematurity development and treatment need with machine learning models

BMC Ophthalmol

Durmaz Engin C, Ozturk T, Ozkan O, Oztas A, Selver MA, Tuzun F

doi: 10.1186/s12886-025-04025-8

Blindness and Vision ImpairmentRetinal Diseases

Management of retinopathy of prematurity in the anti-VEGF era: Consensus and recommendations from the Taiwan Pediatric Retina (TPR) Group

Am J Ophthalmol

Lai TT, Chen YC, Chi SC, Ho MM, Hsia NY, Chen SN, Chen YH, Chou YB, Lai YH, Lin HJ, Tsai HL, Tsai TH, Yeh PT, Wu WC

doi: 10.1016/j.ajo.2025.09.050

Retinal Diseases

Placental Transcriptomic Analysis in Retinopathy of Prematurity Reactivation after Anti-VEGF Treatment

Am J Ophthalmol

Kang J, Kim S, Bae JG, Jang JH

doi: 10.1016/j.ajo.2025.07.023

Retinal Diseases

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Diabetes Obes Metab

Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED

doi: 10.1111/dom.70049

Further Publications

Identification of tear lipid biomarkers in women with dry eye disease and the impact of intense pulsed light therapy: a case-control study

BMC Ophthalmol

Acera A, Ibarrondo O, Mateo-Orobia AJ, Pereiro X, Abad-García B, López-Plandolit S, Ruzafa N, Romero M, Blasco-Martínez A, Rodríguez FD, Duran JA, Vecino E

doi: 10.1186/s12886-025-04315-1

Macular DiseasesRetinal Diseases

Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration

Acta Ophthalmol

Viggiano P, Santoro M, Boscia G, Porreca A, Borrelli E, Bacherini D, Lombardi L, Fumarola R, Grassi MO, Termite AC, Reibaldi M, Alessio G, Sadda S, Boscia F

doi: 10.1111/aos.17502

Retinal Diseases

Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in Retinopathy of Prematurity

JAMA Ophthalmol

Roti EV, Ni S, Bayhaqi Y, Ostmo SR, Burt SS, Woodward MK, Jackson JD, Coyner AS, Chiang MF, Huang D, Campbell JP, Jian Y, Young BK

doi: 10.1001/jamaophthalmol.2024.5533

Related content

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity

Prediction of retinopathy of prematurity development and treatment need with machine learning models

Management of retinopathy of prematurity in the anti-VEGF era: Consensus and recommendations from the Taiwan Pediatric Retina (TPR) Group

Placental Transcriptomic Analysis in Retinopathy of Prematurity Reactivation after Anti-VEGF Treatment

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Identification of tear lipid biomarkers in women with dry eye disease and the impact of intense pulsed light therapy: a case-control study

Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration

Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in Retinopathy of Prematurity